102 related articles for article (PubMed ID: 7163815)
1. Studies with ifosfamide in patients with malignant lymphoma.
Rodriguez V; Cabanillas F; Bodey GP; Freireich EJ
Semin Oncol; 1982 Dec; 9(4 Suppl 1):87-92. PubMed ID: 7163815
[No Abstract] [Full Text] [Related]
2. Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphoma.
Cabanillas F; Rodriguez V; Bodey GP
Cancer Treat Rep; 1980; 64(8-9):933-7. PubMed ID: 7004634
[No Abstract] [Full Text] [Related]
3. Ifosfamide in the management of malignant melanoma: a Southwest Oncology Group Phase II Study.
Costanzi JJ; Stephens R; O'Bryan R; Franks J
Semin Oncol; 1982 Dec; 9(4 Suppl 1):93-5. PubMed ID: 7163816
[No Abstract] [Full Text] [Related]
4. Ifosfamide: European perspective.
Burkert H
Semin Oncol; 1982 Dec; 9(4 Suppl 1):28-35. PubMed ID: 6761866
[No Abstract] [Full Text] [Related]
5. Phase I clinical study of acetylcysteine's preventing ifosfamide-induced hematuria.
Slavik M; Saiers JH
Semin Oncol; 1983 Mar; 10(1 Suppl 1):62-5. PubMed ID: 6836328
[No Abstract] [Full Text] [Related]
6. N-acetylcysteine and ifosfamide in the treatment of unresectable pancreatic adenocarcinoma and refractory testicular cancer.
Loehrer PJ; Williams SD; Einhorn LH
Semin Oncol; 1983 Mar; 10(1 Suppl 1):72-5. PubMed ID: 6836331
[No Abstract] [Full Text] [Related]
7. [Clinical efficacy of four-drug combination treatment of adriamycin, vincristine, ifosfamide, and prednisolone for patients with malignant lymphoma, especially relapsed or refractory types (author's transl)].
Kimura I; Ohnoshi T; Oka A; Nakata Y; Hayashi K; Sato M; Nishihara R; Tanaka T; Sezaki T
Rinsho Ketsueki; 1980 Jun; 21(6):785-91. PubMed ID: 7463736
[No Abstract] [Full Text] [Related]
8. [Ifosfamide in the treatment of small cell carcinoma of the lung].
Mukouda K; Morikawa E; Hasegawa K; Noumi K; Ohmura T; Mishima Y; Kawamoto M; Inagaki A; Kamitsuna A; Yamakido M; Nishimoto Y; Koyama T; Katsuta S
Gan To Kagaku Ryoho; 1983 May; 10(5):1293-8. PubMed ID: 6307164
[TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory malignant neoplasms with ifosfamide as single agent and in combination chemotherapy.
Retsas S
Cancer Treat Rev; 1983 Sep; 10 Suppl A():151-7. PubMed ID: 6627241
[No Abstract] [Full Text] [Related]
10. In vivo perturbation of human marrow cell cycle progression by ifosfamide.
Rentschler RE; Barlogie B; Johnston DA; Bodey GP
Cancer Res; 1978 Aug; 38(8):2209-15. PubMed ID: 667817
[No Abstract] [Full Text] [Related]
11. Prophylaxis of ifosfamide toxicity with oral acetylcysteine.
Holoye PY; Duelge J; Hansen RM; Ritch PS; Anderson T
Semin Oncol; 1983 Mar; 10(1 Suppl 1):66-71. PubMed ID: 6836329
[No Abstract] [Full Text] [Related]
12. Ifosfamide in the treatment of extensive non-oat cell carcinoma of the lung.
Costanzi JJ; Morgan LR; Hokanson J
Semin Oncol; 1982 Dec; 9(4 Suppl 1):61-5. PubMed ID: 6298945
[No Abstract] [Full Text] [Related]
13. Phase I clinical trial of a 3-day divided dose schedule of ifosfamide (NSC 109724).
Nelson RL; Creaven PJ; Cohen MH; Fossieck BE
Eur J Cancer (1965); 1976 Mar; 12(3):195-8. PubMed ID: 780113
[No Abstract] [Full Text] [Related]
14. Ifosfamide in experimental tumor systems.
Goldin A
Semin Oncol; 1982 Dec; 9(4 Suppl 1):14-23. PubMed ID: 6761864
[No Abstract] [Full Text] [Related]
15. Single-dose ifosfamide: efficacy studies in non-small cell lung cancer.
Harrison EF; Hawke JE; Hunter HL; Costanzi JJ; Morgan LR; Plotkin D; Tucker WG; Worrall PM
Semin Oncol; 1982 Dec; 9(4 Suppl 1):56-60. PubMed ID: 6298944
[No Abstract] [Full Text] [Related]
16. High-dose ifosfamide in advanced osteosarcoma.
Marti C; Kroner T; Remagen W; Berchtold W; Cserhati M; Varini M
Cancer Treat Rep; 1985 Jan; 69(1):115-7. PubMed ID: 3855382
[TBL] [Abstract][Full Text] [Related]
17. Studies on the clinical pharmacology and toxicology of isophosphamide (NSC-109724).
Creaven PJ; Allen LM; Cohen MH; Nelson RL
Cancer Treat Rep; 1976 Apr; 60(4):445-9. PubMed ID: 1277220
[No Abstract] [Full Text] [Related]
18. Toxicity of single- vs. fractionated-dose ifosfamide in non-small cell lung cancer: a multi-center study.
Morgan LR; Harrison EF; Hawke JE; Hunter HL; Costanzi JJ; Plotkin D; Tucker WG; Worrall PM
Semin Oncol; 1982 Dec; 9(4 Suppl 1):66-70. PubMed ID: 7163813
[No Abstract] [Full Text] [Related]
19. Protective effect of N-acetylcysteine on the urotoxicity produced by oxazaphosphorine without interference with anticancer activity.
Morgan LR; Donley PJ; Harrison EF; Hunter HL
Eur J Cancer Clin Oncol; 1982 Jan; 18(1):113-4. PubMed ID: 7200891
[No Abstract] [Full Text] [Related]
20. Ifosfamide combinations in lymphoma.
Cabanillas F
Semin Oncol; 1990 Apr; 17(2 Suppl 4):58-62. PubMed ID: 2333524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
